What would a successful pool look like for GSK?
Our hope is that the pool will engender a collaborative approach within industry and between industry and third parties (including academic researchers and, potentially, funding agencies) to deliver real benefits for patients in least developed countries. Timings associated with product development are notoriously difficult to second-guess. However, however long it takes, success for GSK is the same as success for patients – the development of new products for the target neglected tropical diseases.
